Peri-implant Bone Loss
8
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Access to Probing and Peri-implant Diseases
Influence of Implant Insertion Depth on Peri-implant Bone Changes Around Short Implants
Subcrestal vs Juxtacrestal PRAMA Implants With Variable Necks
Ten Year Follow up of Convergent Profile Implants
Salivary Minerals in Patients With Peri-implantitis
Changes on the Interproximal Bone Level on Direct Prostheses or With Intermediate Abutments
Influence of the Design of the Transmucosal Abutment on the Periimplant Bone Level
Comparison Between Two Different Tissue-Level Implant Systems: A Prospective Clinical Study